SCHEMBL7213580

SCHEMBL7213580

Cc1ccc(-c2ccc(C=O)cc2)cc1C.Cc1ccc(Br)cc1C

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.41
ALDH1A1 P00352 5/20 0.40
KIF11 P52732 1/20 0.39
MCL1 Q07820 1/20 0.37
AURKA O14965 1/20 0.36
AURKB Q96GD4 1/20 0.36
DRD1 P21728 2/20 0.36
ALDH1A3 P47895 1/20 0.36
BRD4 O60885 1/20 0.36
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ERN1 O75460 1/20 0.34
EGFR P00533 1/20 0.34
TYR P14679 1/20 0.33
CYP2A13 Q16696 1/20 0.33
LMNA P02545 1/20 0.33
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3456595 0.89 CYP2A6 (0.50) CYP2A6ALDH1A1KIF11MCL1DRD1
SCHEMBL11322374 0.80 CYP2A6 (0.45) CYP2A6ALDH1A1KIF11DRD1ALDH1A3
SCHEMBL258580 0.77 ALDH1A1 (0.48) CYP2A6ALDH1A1KIF11DRD1TYR
SCHEMBL30185443 0.74 ALDH1A1 (0.61) CYP2A6ALDH1A1KIF11DRD1TSHR
SCHEMBL3360913 0.74 CYP2A6 (0.46) CYP2A6ALDH1A1KIF11DRD1BRD4
SCHEMBL30185445 0.74 ALDH1A1 (0.61) CYP2A6ALDH1A1KIF11DRD1TSHR
SCHEMBL3362775 0.74 ALDH1A1 (0.61) CYP2A6ALDH1A1KIF11DRD1TSHR
SCHEMBL40336 0.74
SCHEMBL29419590 0.74
SCHEMBL5734465 0.73 TRIM24 (0.54) CYP2A6ALDH1A1MCL1DRD1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326841-A1 PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS SmithKline Beecham P.L.C. (GB) 2003-07-16 EP disclosed
WO-2002030904-A1 PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM P.L.C. (GB) 2002-04-18 WO disclosed